Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Alper

Showing results (11-20 of 207) with videos related to

Pageof 21
Sort By:
Vox Sanguinis|January 1, 1973
Genetics and the C3 moleculeC A Alper
The New England Journal of Medicine|July 19, 1973
B-lymphocyte malignancyC A Alper
Reviews in Immunogenetics|March 21, 2001
Genetics of the complement systemK Crawford, C A Alper
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 20, 1974
Changes in serum proteinase inhibitor levels following bone surgeryI Dickson, C A Alper
Tissue Antigens|October 18, 2000
Incomplete penetrance of MHC susceptibility genes: prospective analysis of polygenic MHC-determined traitsC A Alper, Z Awdeh
Science (New York, N.Y.)|March 26, 1976
Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement)C A Alper, D Balavitch
Biochimica Et Biophysica Acta|December 22, 1970
Isolation and properties of a glycine-rich beta-glycoprotein of human serumT Boenisch, C A Alper
Biochimica Et Biophysica Acta|July 27, 1970
Isolation and properties of a glycine-rich gamma-glycoprotein of human serumT Boenisch, C A Alper
Vox Sanguinis|January 1, 1993
Immunofixation electrophoresis: a technique for the study of protein polymorphism. Vox Sang 1969:17:445-52C A Alper, A M Johnson
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1972
Hemolytic efficiencies of genetic variants of human C3H R Colten, C A Alper
Pageof 21

Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
Vox Sanguinis|January 1, 1973
Genetics and the C3 moleculeC A Alper
The New England Journal of Medicine|July 19, 1973
B-lymphocyte malignancyC A Alper
Reviews in Immunogenetics|March 21, 2001
Genetics of the complement systemK Crawford, C A Alper
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 20, 1974
Changes in serum proteinase inhibitor levels following bone surgeryI Dickson, C A Alper
Tissue Antigens|October 18, 2000
Incomplete penetrance of MHC susceptibility genes: prospective analysis of polygenic MHC-determined traitsC A Alper, Z Awdeh
Science (New York, N.Y.)|March 26, 1976
Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement)C A Alper, D Balavitch
Biochimica Et Biophysica Acta|December 22, 1970
Isolation and properties of a glycine-rich beta-glycoprotein of human serumT Boenisch, C A Alper
Biochimica Et Biophysica Acta|July 27, 1970
Isolation and properties of a glycine-rich gamma-glycoprotein of human serumT Boenisch, C A Alper
Vox Sanguinis|January 1, 1993
Immunofixation electrophoresis: a technique for the study of protein polymorphism. Vox Sang 1969:17:445-52C A Alper, A M Johnson
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1972
Hemolytic efficiencies of genetic variants of human C3H R Colten, C A Alper
Pageof 21